{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:11:14Z","timestamp":1786997474158,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015401","name":"Key Research and Development Projects of Shaanxi Province","doi-asserted-by":"publisher","award":["2023-ZDLSF-18"],"award-info":[{"award-number":["2023-ZDLSF-18"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015401","name":"Key Research and Development Projects of Shaanxi Province","doi-asserted-by":"publisher","award":["2024SF2-GJHX-30"],"award-info":[{"award-number":["2024SF2-GJHX-30"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015401","name":"Key Research and Development Projects of Shaanxi Province","doi-asserted-by":"publisher","award":["2023-YBSF-362"],"award-info":[{"award-number":["2023-YBSF-362"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32071406"],"award-info":[{"award-number":["32071406"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31470535"],"award-info":[{"award-number":["31470535"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32101147"],"award-info":[{"award-number":["32101147"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82350124"],"award-info":[{"award-number":["82350124"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005320","name":"Xidian University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515030207"],"award-info":[{"award-number":["2023A1515030207"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Biotechnology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.tibtech.2025.01.007","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T14:14:57Z","timestamp":1739628897000},"page":"1196-1214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["An epigenetic regulator synergizes with alphavirus-mediated gene therapy via biomimetic delivery for enhanced cancer therapy"],"prefix":"10.1016","volume":"43","author":[{"given":"Yuqiong","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maozhi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyu","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinruo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dashan","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7370-9457","authenticated-orcid":false,"given":"Pengbo","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tibtech.2025.01.007_bb0005","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3390\/ph16101416","article-title":"Current state of human gene therapy: approved products and vectors","volume":"16","author":"Shchaslyvyi","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.tibtech.2025.01.007_bb0010","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41586-024-07800-7","article-title":"A roadmap for affordable genetic medicines","volume":"634","author":"Kliegman","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.tibtech.2025.01.007_bb0015","first-page":"67","article-title":"The current status of gene therapy for the treatment of cancer","volume":"15","author":"Belete","year":"2021","journal-title":"Biologics"},{"key":"10.1016\/j.tibtech.2025.01.007_bb0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41434-020-00197-8","article-title":"Gene therapy and gene correction: targets, progress, and challenges for treating human diseases","volume":"29","author":"Cring","year":"2022","journal-title":"Gene Ther."},{"key":"10.1016\/j.tibtech.2025.01.007_bb0025","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2217\/fon.10.66","article-title":"OPTIM trial: a Phase III trial of an oncolytic herpes virus encoding GM-CSF for unresectable stage III or IV melanoma","volume":"6","author":"Kaufman","year":"2010","journal-title":"Future Oncol."},{"key":"10.1016\/j.tibtech.2025.01.007_bb0030","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41568-023-00658-3","article-title":"Translating p53-based therapies for cancer into the clinic","volume":"24","author":"Peuget","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tibtech.2025.01.007_bb0035","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41417-021-00331-7","article-title":"Vector engineering, strategies and targets in cancer gene therapy","volume":"29","author":"Singh","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.tibtech.2025.01.007_bb0040","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/s41434-023-00390-5","article-title":"Successes and challenges in clinical gene therapy","volume":"30","author":"Kohn","year":"2023","journal-title":"Gene Ther."},{"key":"10.1016\/j.tibtech.2025.01.007_bb0045","article-title":"Inorganic nanomaterial-mediated gene therapy in combination with other antitumor treatment modalities","volume":"31","author":"Lin","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.tibtech.2025.01.007_bb0050","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.semcancer.2020.07.005","article-title":"Targeting p53 for the treatment of cancer","volume":"79","author":"Duffy","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.tibtech.2025.01.007_bb0055","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.7150\/thno.81847","article-title":"Role of p53 in breast cancer progression: an insight into p53 targeted therapy","volume":"13","author":"Marvalim","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.tibtech.2025.01.007_bb0060","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41573-022-00571-8","article-title":"Drugging p53 in cancer: one protein, many targets","volume":"22","author":"Hassin","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tibtech.2025.01.007_bb0065","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.ccell.2024.04.009","article-title":"Understanding the complexity of p53 in a new era of tumor suppression","volume":"42","author":"Liu","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tibtech.2025.01.007_bb0070","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/cdd.2017.185","article-title":"Mutant p53 partners in crime","volume":"25","author":"Kim","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.tibtech.2025.01.007_bb0075","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41392-023-01347-1","article-title":"Targeting p53 pathways: mechanisms, structures, and advances in therapy","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.tibtech.2025.01.007_bb0080","doi-asserted-by":"crossref","DOI":"10.1126\/science.aax0182","article-title":"Neoadjuvant checkpoint blockade for cancer immunotherapy","volume":"367","author":"Topalian","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.tibtech.2025.01.007_bb0085","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1016\/j.cell.2022.07.006","article-title":"Immune checkpoint blockade provokes resident memory T cells to eliminate head and neck cancer","volume":"185","author":"Veatch","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.tibtech.2025.01.007_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202011171","article-title":"Nanomedicine-boosting tumor immunogenicity for enhanced immunotherapy","volume":"31","author":"Huang","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.tibtech.2025.01.007_bb0095","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41578-019-0108-1","article-title":"Cancer nanomedicine for combination cancer immunotherapy","volume":"4","author":"Nam","year":"2019","journal-title":"Nature Rev. Mater."},{"key":"10.1016\/j.tibtech.2025.01.007_bb0100","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0966-842X(00)01936-3","article-title":"Pro-inflammatory programmed cell death","volume":"9","author":"Cookson","year":"2001","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.tibtech.2025.01.007_bb0105","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1016\/j.molcel.2021.09.003","article-title":"Molecular mechanisms and functions of pyroptosis in inflammation and antitumor immunity","volume":"81","author":"Hou","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tibtech.2025.01.007_bb0110","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.7150\/thno.71086","article-title":"Pyroptosis in inflammatory diseases and cancer","volume":"12","author":"Rao","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.tibtech.2025.01.007_bb0115","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.7150\/ijbs.86855","article-title":"Molecular mechanisms of pyroptosis and its role in anti-tumor immunity","volume":"19","author":"Huang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.tibtech.2025.01.007_bb0120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature22393","article-title":"Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin","volume":"547","author":"Wang","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.tibtech.2025.01.007_bb0125","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41420-020-00349-0","article-title":"The caspase-3\/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer","volume":"6","author":"Jiang","year":"2020","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.tibtech.2025.01.007_bb0130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41577-019-0228-2","article-title":"The gasdermins, a protein family executing cell death and inflammation","volume":"20","author":"Broz","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tibtech.2025.01.007_bb0135","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13148-018-0479-y","article-title":"Large-scale analysis of DFNA5 methylation reveals its potential as biomarker for breast cancer","volume":"10","author":"Croes","year":"2018","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.tibtech.2025.01.007_bb0140","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41586-020-2071-9","article-title":"Gasdermin E suppresses tumour growth by activating anti-tumour immunity","volume":"579","author":"Zhang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.tibtech.2025.01.007_bb0145","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S1525-0016(02)00056-4","article-title":"Novel Semliki Forest virus vectors with reduced cytotoxicity and temperature sensitivity for long-term enhancement of transgene expression","volume":"7","author":"Lundstrom","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tibtech.2025.01.007_bb0150","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.virusres.2010.07.027","article-title":"Alphavirus vectors for cancer therapy","volume":"153","author":"Quetglas","year":"2010","journal-title":"Virus Res."},{"key":"10.1016\/j.tibtech.2025.01.007_bb0155","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/gt.2011.99","article-title":"A Semliki Forest virus vector engineered to express IFN\u03b1 induces efficient elimination of established tumors","volume":"19","author":"Quetglas","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.tibtech.2025.01.007_bb0160","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1016\/j.vaccine.2012.03.049","article-title":"Enhancement of the immunogenicity of an alphavirus replicon-based DNA vaccine against classical swine fever by electroporation and coinjection with a plasmid expressing porcine interleukin 2","volume":"30","author":"Tian","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.tibtech.2025.01.007_bb0165","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1016\/j.ymthe.2019.09.016","article-title":"Short-term local expression of a PD-L1 blocking antibody from a self-replicating RNA vector induces potent antitumor responses","volume":"27","author":"Ballesteros-Briones","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tibtech.2025.01.007_bb0170","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ymthe.2020.11.002","article-title":"First-in-human Phase I clinical trial of an SFV-based RNA replicon cancer vaccine against HPV-induced cancers","volume":"29","author":"Komdeur","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tibtech.2025.01.007_bb0175","article-title":"Filamentous-actin-mimicking nanoplatform for enhanced cytosolic protein delivery","volume":"11","author":"Xia","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.tibtech.2025.01.007_bb0180","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00232-022-00267-5","article-title":"Lipid and lipidation in membrane fusion","volume":"255","author":"Sardar","year":"2022","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.tibtech.2025.01.007_bb0185","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1016\/j.cell.2024.07.023","article-title":"Safe and effective in vivo delivery of DNA and RNA using proteolipid vehicles","volume":"187","author":"Brown","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.tibtech.2025.01.007_bb0190","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/vaccines7010029","article-title":"Plasmid DNA-based alphavirus vaccines","volume":"7","author":"Lundstrom","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.tibtech.2025.01.007_bb0195","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1099\/0022-1317-79-10-2405","article-title":"The Semliki Forest virus vector induces p53-independent apoptosis","volume":"79","author":"Glasgow","year":"1998","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.tibtech.2025.01.007_bb0200","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nbt0698-562","article-title":"Enhancing immune responses using suicidal DNA vaccines","volume":"16","author":"Berglund","year":"1998","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tibtech.2025.01.007_bb0205","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41467-022-28279-8","article-title":"Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy","volume":"13","author":"Xiao","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tibtech.2025.01.007_bb0210","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005068","article-title":"Restoration of p53 activity via intracellular protein delivery sensitizes triple negative breast cancer to anti-PD-1 immunotherapy","volume":"10","author":"Yang","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.tibtech.2025.01.007_bb0215","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.molcel.2019.02.013","article-title":"Apoptotic caspases suppress type I interferon production via the cleavage of cGAS, MAVS, and IRF3","volume":"74","author":"Ning","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tibtech.2025.01.007_bb0220","doi-asserted-by":"crossref","first-page":"8049","DOI":"10.1021\/acs.nanolett.9b03245","article-title":"Epigenetics-based tumor cells pyroptosis for enhancing the immunological effect of chemotherapeutic nanocarriers","volume":"19","author":"Fan","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.tibtech.2025.01.007_bb0225","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.7150\/thno.79945","article-title":"Sonodynamic-immunomodulatory nanostimulators activate pyroptosis and remodel tumor microenvironment for enhanced tumor immunotherapy","volume":"13","author":"Chen","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.tibtech.2025.01.007_bb0230","article-title":"Injectable autocatalytic hydrogel triggers pyroptosis to stimulate anticancer immune response for preventing postoperative tumor recurrence","volume":"12","author":"Rao","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.tibtech.2025.01.007_bb0235","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40364-022-00391-3","article-title":"The role of pyroptosis in modulating the tumor immune microenvironment","volume":"10","author":"Wu","year":"2022","journal-title":"Biomark. Res."},{"key":"10.1016\/j.tibtech.2025.01.007_bb0240","article-title":"Biomaterials elicit pyroptosis enhancing cancer immunotherapy","volume":"34","author":"Zhang","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.tibtech.2025.01.007_bb0245","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jconrel.2024.11.064","article-title":"An engineered \u03b11\u03b21 integrin-mediated Fc\u03b3RI signaling component to control enhanced CAR macrophage activation and phagocytosis","volume":"377","author":"Du","year":"2025","journal-title":"J. Control. Release"}],"container-title":["Trends in Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167779925000071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167779925000071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T11:38:32Z","timestamp":1762256312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167779925000071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0167779925000071"],"URL":"https:\/\/doi.org\/10.1016\/j.tibtech.2025.01.007","relation":{},"ISSN":["0167-7799"],"issn-type":[{"value":"0167-7799","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An epigenetic regulator synergizes with alphavirus-mediated gene therapy via biomimetic delivery for enhanced cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Trends in Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tibtech.2025.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}